Roche beefs up R&D with $190M Ontario center

Roche is plugging a Canadian biotech hub into its growing network of global R&D centers. The pharma giant has selected Ontario as the site of its next big drug research complex, promising to invest up to $190 million over 5 years and hire some 200 research staffers. Report

Suggested Articles

The future may be uncertain for AZ’s Imfinzi in first-line lung cancer, but its targeted med Tagrisso now boasts a green light in that setting.

Ultragenyx is back with another FDA nod, this time for Crysvita to treat X-linked hypophosphatemia in patients one year and older.

Roche got a two pieces of good Hemlibra news early this week—and what's good for Hemlibra must be good for Roche.